Topological patterns of damage and compensation in chronic neuroinflammation

B05

Although research has made significant progress, there are still mechanistic factors that markedly influence disease progression and compensation reserve, making an accurate prognosis of sub-group and individual disease courses in MS extremely challenging. We aim at elaborating the framework for the automatic stratification of disease courses and therapeutic responses. Using advanced magnetic resonance imaging (MRI) together with brain networks phenotyping and immune response analyses, we aim to early recognize patients at high risk for disease progression (i.e. evolving functional impairment) or with insufficient therapeutic responses to immunomodulation:

    1. Can the acute individual network response help to predict future relapses and long-term disease trajectories?
    2. What is the difference in chronic network responses between patients with continuous functional worsening compared to clinically stable patients?
    3. How do the predictive differences of grey matter (GM) and white matter (WM) lesion localization impact on network dynamics and disease progression?
    4. What is the role of cortical lesions and their corresponding dynamics (enlarging, smoldering lesions) for WM and GM network reorganization and evolving functional impairment?
    5. Can peripheral immunological markers be linked to data from MRI network analysis to improve the understanding of the pathomechanisms underlying network reorganization in MS?

 

 

 

 

 

 

 

 

 

 

 

Principal Investigators:

Prof. Dr. med. Sergiu Groppa
Klinik für Neurologie
Mainz
segroppa@uni-mainz.de

Prof. Dr.-Ing. Muthuraman Muthuraman
Klinik für Neurologie
Mainz
mmuthura@uni-mainz.de

Univ.-Prof. Dr. med. Dr. rer. nat. Dr. h.c. Sven G. Meuth
Klinik für Neurologie
Düsseldorf
sven.meuth@med.uni-duesseldorf.de

News

Tue, 28/06/2022
CRC Retreat in Münster
Muenster. After a long pause, more than 90 participants of the CRC joined in Muenster Factory Hotel to update on the latest developments. We heard the most recent on a selection of the CRC projects and there was also plenty of time for fruitful discussion and socializing in the evening....more
Mon, 23/05/2022
EU Research Council awards Lydia Sorokin Advanced Grant
Münster – The biochemist and Principal investigator of the CRC 128 Prof. Dr. Lydia Sorokin has received the coveted “Advanced Grant” awarded by the European Research Council (ERC). The funding of ca. 2.3 million euros enables the realisation of outstanding research projects. Lydia Sorokin heads the Institute for Physiological Chemistry and Pathobiochemistry at Muenster University. […]...more
Wed, 19/01/2022
One drug – different effects: Metabolism of immune cells influences mode of action and could be an indicator for side effects
Muenster – One person can eat large amounts of pasta and still be a small dress size while another looks at a piece of chocolate and puts on weight: metabolism varies between individuals – and this goes beyond a subjective feeling. What is apparent in the overall organism also applies to each cell: the metabolism […]...more